Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MLL-directed interferon alfa prophylaxis after allogeneic stem cell transplantation in acute leukemia
ChiCTR1800016741Phase 2Recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Jul 2018
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of interferon alfa in Acute Leukaemia, sponsored by Peking University People's Hospital. Primary endpoint: Relapse. Started Jul 2018; status: recruiting.
02
Drugs
interferon alfa
03
Conditions
Acute Leukaemia
Beyond the preview
Go deeper on ChiCTR1800016741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016741.